NCT01826266
- Conditions
- Anticoagulant Reversal, Reversal of Edoxaban Induced Anticoagulation
- Locations
-
- Duke Clinical Research, Unit 200 Durham, North Carolina, United States
Clinical trial condition
Explore clinical trials studying Reversal of Edoxaban Induced Anticoagulation. Study availability and eligibility vary by location and protocol.
NCT01826266